ICON Opens New Asian Offices To Keep Pace With Growing Demand For More Trials In Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Ireland-headquartered global contract research organization ICON is expanding its presence in the Asia Pacific region due to the growing attractiveness of conducting clinical trials in the region
You may also be interested in...
Spurred By Demand For Global And Regional Trials In India, China And Japan, ICON Charts Asia Growth Strategy
SINGAPORE - Malcolm Burgess, Executive VP Asia Pacific with Ireland-headquartered ICON Plc - one of the fastest growing contract research organizations in Asia - expresses satisfaction that over the past seven years he could develop a close bonding with his 600 plus staffers based in the medium-sized cities of Chennai and Thiruvananthapuram at the southern tip of India
Spurred By Demand For Global And Regional Trials In India, China And Japan, ICON Charts Asia Growth Strategy
SINGAPORE - Malcolm Burgess, Executive VP Asia Pacific with Ireland-headquartered ICON Plc - one of the fastest growing contract research organizations in Asia - expresses satisfaction that over the past seven years he could develop a close bonding with his 600 plus staffers based in the medium-sized cities of Chennai and Thiruvananthapuram at the southern tip of India
ICON Expands Asia Pacific Footprint With New Focus On Southeast Asian Countries
SHANGHAI - Driven by increasing interest for drug development programs in Southeast Asia, Ireland-based ICON is expanding its Asia Pacific footprint in the Philippines